Epstein Secrets

told Reuters." The Washington Times <https://www.washingtontimes.corn/news/2020/nov/12/cisa-no-evidence-changed- compromised-deleted-or-lo/> (11/12, Lovelace, 492K) reports that among the parties issuing the statement are "members such as CISA assistant director Bob Kolasky, U.S. Election Assistance Commi

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

EO Jack Dorsey. The Washington Times <https://www.washingtontimes.com/news/2020/oct/22/senate-judiciary-committee-votes-subpoena-twitter-/> (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

" and CISA Director Krebs "has told associates he expects to be fired, sources familiar with the matter told Reuters." The Washington Times (11/12, Lovelace, 492K) reports that among the parties issuing the statement are "members such as CISA assistant director Bob Kolasky, U.S. Election Assistance Comm

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

Chairman Lindsey Graham to issue subpoenas EFTA00148455 to Facebook CEO Mark Zuckerberg and Twitter CEO Jack Dorsey. The Washington Times (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

g on the story was provided by Axios (07/01, Sabin), Security Affairs (07/01, Paganini), SecurityWeek (07/01, Kovacs), and Washington Times (07/01, Lovelace). Back to Top COUNTERTERRORISM 16 Alleged 'Anti-Trent Members Charged in Houston With Drug and Gun Trafficking KIAH (CW-39) (07/01, Estrada) and

ng part of his Pistons paycheck seized, public records show. According to the article, court records paint a picture of a turbulent personal life as Beasley experienced a career breakthrough with the Pistons last season and while debts mounted from a celebrity barber, a dentist, a landlord, a lender and

" and CISA Director Krebs "has told associates he expects to be fired, sources familiar with the matter told Reuters." The Washington Times (11/12, Lovelace, 492K) reports that among the parties issuing the statement are "members such as CISA assistant director Bob Kolasky, U.S. Election Assistance Comm

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

has authorized Chairman Lindsey Graham to issue subpoenas to Facebook CEO Mark Zuckerberg and Twitter CEO Jack Dorsey. The Washington Times (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-